Parkside Financial Bank & Trust’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,000
Closed -$2.11K 2122
2024
Q1
$2.11K Hold
3,000
﹤0.01% 1503
2023
Q4
$5.25K Buy
3,000
+1,000
+50% +$1.46K ﹤0.01% 1294
2023
Q3
$2.88K Buy
2,000
+300
+18% +$750 ﹤0.01% 1549
2023
Q2
$4.42K Hold
1,700
﹤0.01% 1419
2023
Q1
$6.26K Hold
1,700
﹤0.01% 1276
2022
Q4
$3.01K Hold
1,700
﹤0.01% 1534
2022
Q3
$7K Buy
+1,700
New +$10.5K ﹤0.01% 1128

Other funds holding DMTK

Parkside Financial Bank & Trust's DMTK Position: Q2 2024 in Review

Parkside Financial Bank & Trust sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 3,000 shares — an estimated $2.11K sold.

Parkside Financial Bank & Trust first reported a position in DMTK in Q3 2022 and held it in 7 quarters. The position peaked at $7K in Q3 2022. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Parkside Financial Bank & Trust reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 3,000 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $2.11K.
  • Parkside Financial Bank & Trust first reported a position in DermTech, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Parkside Financial Bank & Trust's DermTech, Inc. Common Stock position peaked at $7K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2024, filed 5 Aug 2024.